Biomeme Inc

Biomeme’s NextGen molecular testing platform sets a new standard in biodefense—smaller, faster, and more capable. Engineered for extreme portability and accelerated workflows, it delivers rapid DNA/RNA identification at the point of need, enabling decisive CBRN readiness for Federal Agencies, State & Local Authorities, and Military teams, with expanded capabilities and secure connectivity for any mission.